Niquitin Minilozenge Citrus 4 (Nicotine)

Nicotine, the active ingredient in Niquitin Minilozenge Citrus 4, is a nicotine replacement therapy presented as an oromucosal lozenge for adult smokers seeking cessation. It works by delivering controlled nicotine to alleviate withdrawal symptoms and reduce cravings during quit attempts.

GNH USA supplies Niquitin Minilozenge Citrus 4 as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards. The company ensures product quality, traceability and compliance with Good Distribution Practice throughout the supply chain.

Niquitin Minilozenge Citrus 4 is a nicotine replacement therapy used in smoking cessation. - Smoking cessation: assists adult smokers in quitting by reducing withdrawal symptoms. - Nicotine dependence: provides a controlled nicotine dose to manage cravings. - Tobacco use disorder: supports gradual reduction of tobacco intake during quit attempts.

Common Side Effects: - Mouth irritation or soreness. - Hiccups or throat discomfort. - Nausea or mild dyspepsia. - Increased salivation. - Dysgeusia (altered taste). - Dizziness.

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing). - Chest pain or palpitations. - Severe nausea or vomiting. - Hypotension or fainting. - Arrhythmias. - Seizures (rare).

Precautions for Niquitin Minilozenge Citrus 4 include: - Assess nicotine dependence level: determine appropriate lozenge strength. - Avoid use in non‑smokers or recent quitters: risk of nicotine overdose. - Monitor cardiovascular status: use cautiously in patients with heart disease. - Consider pregnancy and lactation: safety not established; weigh benefits vs risks. - Do not exceed recommended daily lozenge count: follow prescriber guidance. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Potential drug interactions for Niquitin Minilozenge Citrus 4 are: Major Interactions (Avoid): - Concurrent use of other nicotine replacement products: risk of nicotine toxicity. - Use with bupropion: may increase seizure risk. Moderate Interactions (Monitor Closely): - Use with certain antihypertensives (beta‑blockers): may blunt blood pressure response. - CYP2A6 inhibitors (e.g., methoxsalen): may increase nicotine levels. - Alcohol or high caffeine intake: may enhance nicotine's cardiovascular effects.